Hyunsil Han

Hyunsil Han is an experienced Director of Clinical Research specializing in Oncology and Translational Science at Regeneron since October 2018, having previously served as Associate Director in the same field. Prior to Regeneron, Hyunsil Han worked at Novartis Pharmaceuticals from January 2016 to October 2018 as a Global Trial Manager, focusing on managing a Phase 3 immuno-oncology trial and leading protocol development. Earlier career experience includes a role as Clinical Research Scientist/Project Manager at SK Life Science, Inc. from April 2005 to January 2016, where responsibilities included clinical development support and protocol collaboration with senior leadership, as well as serving as Study Director for nonclinical safety testing with a focus on in vitro toxicity evaluations. Hyunsil Han holds a Doctor of Philosophy in Immunology from Joan & Sanford I. Weill Medical College of Cornell University and a B.S. in Food Engineering from Yonsei University.